Leaking gut in type 1 diabetes

Current Opinion in Gastroenterology

Volumn 24, Issue 6, 2008, Pages 701-706

  Vaarala, Outi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Cell autoimmunity; Enteral infections; Intestinal permeability; Oral tolerance

Indexed keywords

INSULIN; INTERLEUKIN 10; INTERLEUKIN 18; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZONULIN;

AUTOIMMUNITY; CELL DESTRUCTION; DIETARY INTAKE; DISEASE ASSOCIATION; ENTERITIS; ENTEROPATHY; ENTEROVIRUS INFECTION; GENETIC RISK; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LEAKY GUT SYNDROME; NONHUMAN; PANCREAS ISLET BETA CELL; PROPHYLAXIS; REVIEW; T LYMPHOCYTE ACTIVATION; TIGHT JUNCTION; VIRUS INFECTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; INTESTINAL DISEASES; INTESTINES; PERMEABILITY; SYNDROME;

EID: 55749100160     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32830e6d98     Document Type: Review

References (44)

1. Westerholm-Ormio M, Vaarala O, Pihkala P, et al. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003; 52:2287-2295.
2. Auricchio R, Paparo F, Maglio M, et al. In-vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004; 53:1680-1683.
3. Tiittanen M, Westerholm-Ormio M, Verkasalo M, et al. Infiltration of Foxp3 expressing cells in jejunal mucosa in celiac disease but not in type 1 diabetes. Clin Exp Immunol 2008; 152:498-507. This study demonstrates that Foxp3 activity is not increased in the small intestine of patients with type 1 diabetes despite the subclinical inflammation, which raises the question of defective regulatory mechanisms.
4. Colgan SP, Resnick MB, Parkos CA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994; 153:2122-2129.
5. Bruewer M, Utech M, Ivanov Al, et al. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis- like process. FASEB J 2005; 19:923-933.
6. Li Q, Zhang Q, Wang M, et al. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008; 126: 67-80. The investigation provides evidence that proinflammatory cytokines cause tight-junction barrier disruption by altering the lipid composition of tight-junctions.
7. Fasano A. Intestinal zonulin: open sesame! Gut 2001; 49:159-162.
8. Graham S, Courtois P, Malaisse WJ, et al. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004; 53:1437-1444.
9. Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA 2005; 102:2916-2921.
10. Neu J, Reverte CM, Mackey AD, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005; 40:589-595.
11. Luopajärvi K, Savilahti E, Virtanen SM, et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes 2008 [Epub ahead of print]. A unique design of the study reveals that the antibody response to dietary cow's milk proteins is altered already during the early infancy in the children who later in life develop type 1 diabetes.
12. TRIGR Study Group. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 2007; 8:117-137.
13. Mooradian AD, Morley JE, Levine AS, et al. Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 1986; 29:221-224.
14. Kuitunen M, Saukkonen T, Honen J, et al. Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DOB1 *02 allele. Autoimmunity 2002; 35:365-368.
15. Secondulfo M, Iafusco D, Carratu R, et al. Ultrastructural mucosal alterations and increased intestinal permeability in nonceliac, type I diabetic patients. Dig Liver Dis 2004; 36:35-45.
16. Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006; 55:1443-1449.
17. Bosi E, Molteni L, Radaelli MG, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006; 49:2824-2827.
18. Turley SJ, Lee JW, Dutton-Swain N, et al. Endocrine self and gut nonself intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 2005; 102:17729-17733.
19. Hänninen A, Nurmela R, Maksimow M, et al. Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol 2007; 170:240-250. A very intriguing study indicating that oral antigen activated T-cells use gut homing receptors to infiltrate the islets in T-cell receptor (TCR) trangenic mouse model of autoimmune diabetes.
20. Lee J, Gonzales-Navajas JM, Raz E. The 'polarizing-tolerizing' mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008; 30:3-9. An excellent review of the importance of the apical TLR-9 stimulation by commensal bacteria in the control of intestinal inflammation.
21. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132:1359-1374. This study provides a mechanistic explanation for TLR-2-mediated control of intestinal inflammation: tight-junction regulation.
22. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49: 2105-2108.
23. Hansen AK, Ling F, Kaas A, et al. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in nonobese diabetic mice. Diabetes Metab Res Rev 2006; 22:220-225.
24. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8:435-446. A very useful review of intestinal dendritic cells as tolerogenic cells.
25. Drescher KM, Tracy SM. The CVB and etiology of type 1 diabetes. Curr Top Microbiol Immunol 2008; 323:259-274. A comprehensive review of the possible role of enteroviruses in the development of type 1 diabetes.
26. Graham KL, Sanders N, Tan Y, et al. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008; 82:6139-6149. This experimental study indicates that rotavirus infections may not cause auto-immune response, but rather activate diabetogenic T-cells when the autoimmunity has already been initiated.
27. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005; 48:1510-1522.
28. Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104:5115-5120. This study provides evidence that human β-cells are infected by Coxsackie virus in vivo and suggests that this may not always be associated with insulitis.
29. Hirata Y, Broquet AH, Menchén L, Kagnoff MF. Activation of innate immune defense mechanisms by signaling through RIG-l/IPS-1 in intestinal epithelial cells. J Immunol 2007; 179:5425-5432.
30. Coyne CB, Shen L, Turner JR, Bergelson JM. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GT Pases Rab34 and Rab5. Cell Host Microbe 2007; 2:181-192. The study provides mechanism for the enterovirus entry from intestine: interference with tight-junction assembly.
31. Nava P, López S, Arias CF, et al. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci 2004; 117:5509-5519.
32. Oikarinen M, Tauriainen S, Honkanen T, et al. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 2008; 151: 71-75. This interesting preliminary finding of the presence of enterovirus in the small intestine of patients with long-term diabetes suggests chronic or recurrent infections in the patients.
33. Skarsvik S, Puranen J, Honkanen J, et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006; 55:996-1003.
34. Lammers KM, Lu R, Brownley J, et al. Gliadin Induces an Increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008; 135:194-204.
35. Chakir H, Lefebvre DE, Wang H, et al. Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats. Diabetologia 2005; 48:1576-1584.
36. Maurano F, Mazzarella G, Luongo D, et al. Small intestinal enteropathy in nonobese diabetic mice fed a diet containing wheat. Diabetologia 2005; 48:931-937.
37. Funda DP, Kaas A, Tlaskalová-Hogenová H, Buschard K. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab Res Rev 2008; 24:59-63.
38. Caicedo RA, Li N, Des Robert C, et al. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatr Res 2008; 63:303-307. This study indicates that early feeding patterns may cause long-lasting immunological changes.
39. Vaarala O. Is it dietary insulin? Ann N Y Acad Sci 2006; 1079:350-359.
40. Mäkelä M, Vaarala O, Hermann R, et al. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 2006; 27:54-61.
41. Santiago JL, Martinez A, Núñez C, et al. Association of MYO9B haplotype with type 1 diabetes. Hum Immunol 2008; 69:112-115. A possible link between genetics and leaking gut in type 1 diabetes: tight-junction myosin gene polymorphism.
42. Zipitis CS, Akobeng AK. Vitamin D supplementation In early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008; 93:512-517.
43. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56:2616-2621.
44. Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294:G208-G216. The study provides in-vitro evidence for the role of vitamin D in the control of intestinal permeability.